In HNSCC, we found that although elevated OPRL1 expression did not confer a clear survival benefit, higher PNOC levels correlated with more favorable clinical outcomes and lower tumor grade (Fig. 1H–J). This evidence concerns the gene OPRL1 and neoplasm.